SEC Form 4 · accession 0000899243-16-011830
Mirati Therapeutics, Inc. · MRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Boxer Capital, LLC
10% Owner
Period of report
Jan 14, 2016
Accepted (ET)
Jan 15, 2016 · 5:50 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jan 14, 2016 | J | 791,139 | $0.00 | D | 1,232,093 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On January 14, 2016, Boxer Capital, LLC ("Boxer Capital") transferred 791,139 shares of the common stock of the issuer, pro-rata for no consideration as part of an internal reorganization.
- F2These securities are owned directly by Boxer Capital, which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Braslyn Ltd., (iii) Boxer Asset Management Inc., (iv) MVA Investors, LLC, (iv) Joe Lewis, (v) Rodney W. Lappe, (vi) Ivan M. Lieberburg, (vii) Aaron I. Davis, (viii) Neil Reisman, (ix) Shehan B. Dissanayake, (x) Christopher Fuglesang (xi) Peter E. Harwin, and (xii) William N. Harwin 2012 Gift Trust F/B/O Peter Harwin.